dexmethylphenidate hydrochloride has been researched along with guanfacine in 2 studies
| Studies (dexmethylphenidate hydrochloride) | Trials (dexmethylphenidate hydrochloride) | Recent Studies (post-2010) (dexmethylphenidate hydrochloride) | Studies (guanfacine) | Trials (guanfacine) | Recent Studies (post-2010) (guanfacine) |
|---|---|---|---|---|---|
| 65 | 27 | 22 | 784 | 180 | 273 |
| Protein | Taxonomy | dexmethylphenidate hydrochloride (IC50) | guanfacine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 1.453 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.134 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.249 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 6.447 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 3.014 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 1.453 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 2.098 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castelo, E; Cowen, J; Levitt, J; McCracken, JT; McGough, JJ; Sayer, GR; Sturm, A | 1 |
| Bucher, BM; Weiner, RL; Wright, BA | 1 |
1 trial(s) available for dexmethylphenidate hydrochloride and guanfacine
| Article | Year |
|---|---|
Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for Attention-Deficit/Hyperactivity Disorder.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dexmethylphenidate Hydrochloride; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Female; Guanfacine; Heart Rate; Humans; Male; Time Factors | 2016 |
1 other study(ies) available for dexmethylphenidate hydrochloride and guanfacine
| Article | Year |
|---|---|
Elevation of sweat chloride levels in a patient with CFTR-related metabolic syndrome receiving dexmethylphenidate and guanfacine.
Topics: Chlorides; Cystic Fibrosis Transmembrane Conductance Regulator; Dexmethylphenidate Hydrochloride; Guanfacine; Humans; Metabolic Syndrome; Mutation; Sweat | 2022 |